6月5日,科伦博泰宣布进行新一轮港股配售。具体而言,此次配售价格为331.8港元/股,因簿记需求强劲,交易规模从最初设定的2亿美元上调至2.5亿美元,成为过去12个月以来港股市场生物医药行业最大规模的新股增发交易。6月12日,公司宣布配售事项完成,募资净额约19.43亿港元(约合2.5亿美元)。其中,80%的资金将用于产品研发、临床试验、注册备案、制造及商业化。科伦博泰是科伦药业实控人刘革新在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.